The commercial blind spot - Bridging the business gap for scientific founders | скачать в хорошем качестве

The commercial blind spot - Bridging the business gap for scientific founders |

The commercial blind spot - Bridging the business gap for scientific founders at Investment Summit, Advanced Therapies Week 2026 While scientific innovation drives breakthroughs in CGT, commercial understanding often determines whether those breakthroughs reach patients – and investors. This session will unpack why strong commercial acumen is just as critical as scientific excellence in securing funding and scaling successfully. Industry leaders and investors will discuss what scientific founders need to know about pricing, reimbursement, and market access, and how early commercial strategy can turn cutting-edge research into investable, sustainable businesses. Key takeaways 🔷 Why commercial acumen is just as important as scientific expertise 🔷 How understanding pricing, reimbursement, and access can attract capital 🔷 Practical ways to build commercial expertise within early-stage biotech teams Chairperson James Zanewicz (CEO | CONNECT) Speakers Chris Barkey (CEO | Swissfinity Group) Raphael Ognar (Chief Executive Officer | NKILT Therapeutics)